Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Wellington Management Group LLP

Key Points

• Wellington Management cut its Sabra Healthcare REIT stake by 44.4% in the second quarter, selling 416,290 shares and retaining 521,899 shares valued at approximately $10.2 million. Institutional investors and hedge funds collectively own 99.4% of SBRA.
• Analyst sentiment is mixed, with six Buy ratings and seven Hold ratings. The stock has an average rating of “Hold” and a consensus price target of $22.17.
• SBRA recently traded at $20.81 and pays a quarterly dividend of $0.30, equivalent to a 5.8% annual yield. Its latest quarterly results missed earnings expectations, although revenue rose 24.7% year over year.

Wellington Management Group LLP trimmed its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 44.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 521,899 shares of the real estate investment trust's stock after selling 416,290 shares during the quarter. Wellington Management Group LLP owned approximately 0.20% of Sabra Healthcare REIT worth $10,182,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Rothschild Investment LLC increased its stake in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 889 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in shares of Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust's stock worth $27,000 after buying an additional 714 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust's stock valued at $29,000 after buying an additional 603 shares during the period. Danske Bank A S acquired a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Finally, Larson Financial Group LLC grew its position in shares of Sabra Healthcare REIT by 42.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock valued at $35,000 after buying an additional 553 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SBRA has been the topic of a number of recent research reports. Citigroup reissued a "market outperform" rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Scotiabank dropped their target price on Sabra Healthcare REIT from $22.00 to $19.00 and set a "sector perform" rating on the stock in a research report on Thursday, June 18th. Truist Financial boosted their price target on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a "buy" rating in a report on Wednesday, July 22nd. Citizens Jmp increased their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a "market outperform" rating in a report on Wednesday, July 22nd. Finally, Wall Street Zen raised shares of Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $22.17.

Sabra Healthcare REIT Stock Up 0.1%

Shares of SBRA stock opened at $20.81 on Wednesday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The business's fifty day moving average is $20.66 and its 200-day moving average is $20.20. The stock has a market cap of $5.32 billion, a PE ratio of 80.04, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. During the same quarter last year, the company earned $0.38 EPS. The company's quarterly revenue was up 24.7% compared to the same quarter last year. Equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 5.8%. Sabra Healthcare REIT's payout ratio is currently 461.54%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.